Natural Product ID:   | NPC316457 |
Common Name:   | n.a. |
IUPAC Name:   | |
Synonyms:   | GNF-Pf-1439 |
Molecular Formula:   | C21H24O9 |
Standard InCHIKey:   | WWNXYRCJJRRWAQ-ALCXHWRFSA-N |
Standard InCHI:   | InChI=1S/C21H24O9/c1-8-14(22)20-15(23)10-6-5-7-11(27-3)12(10)17(28-4)21(20,30-20)18(25)19(8,26)16(24)13-9(2)29-13/h5-9,13-14,17-18,22,25-26H,1-4H3/t8-,9-,13+,14+,17-,18-,19+,20+,21+/m0/s1 |
Canonical SMILES:   | COc1cccc2c1[C@H](OC)[C@@]13[C@@](C2=O)(O1)[C@H](O)[C@@H]([C@@]([C@@H]3O)(O)C(=O)[C@@H]1O[C@H]1C)C |
First Find Year:   | |
Max Developmental Stage:   | |
Synthetic Gene Cluster:   | BGC0001177 ; |
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO25078 | Streptomyces bottropensis | Species | Streptomycetaceae | Bacteria | StreptomeDB* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 264.85 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 40.46 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 210.86 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 196.34 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 249.46 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 310.46 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 194.09 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 281.84 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 271.02 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 172.19 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 168.66 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 259.42 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 252.93 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 276.06 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 299.23 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 232.27 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 337.29 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 216.77 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 303.39 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 297.17 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 202.3 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 286.42 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 212.81 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 318.42 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 210.38 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 184.93 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 317.69 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 221.31 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 149.28 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 172.19 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 207.97 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 236.59 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 289.07 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 175.39 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 198.61 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 233.35 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 255.27 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 317.69 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 246.04 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 187.07 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 266.07 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 293.76 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 210.38 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 312.61 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 258.23 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 297.85 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 272.9 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 214.29 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 218.27 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 229.09 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 234.96 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 264.24 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 224.91 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 155.24 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 219.79 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 334.97 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 230.14 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 244.91 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 164.82 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC316457 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9416 | High Similarity | NPC314257 |
0.9308 | High Similarity | NPC472049 |
0.8924 | High Similarity | NPC68727 |
0.8917 | High Similarity | NPC180944 |
0.8827 | High Similarity | NPC478229 |
0.882 | High Similarity | NPC472055 |
0.8797 | High Similarity | NPC470337 |
0.8797 | High Similarity | NPC470338 |
0.8797 | High Similarity | NPC268992 |
0.8797 | High Similarity | NPC51824 |
0.8797 | High Similarity | NPC113608 |
0.879 | High Similarity | NPC225854 |
0.8765 | High Similarity | NPC478134 |
0.8765 | High Similarity | NPC478222 |
0.8758 | High Similarity | NPC470339 |
0.8704 | High Similarity | NPC284495 |
0.8679 | High Similarity | NPC470340 |
0.8675 | High Similarity | NPC473095 |
0.8675 | High Similarity | NPC473096 |
0.865 | High Similarity | NPC87431 |
0.8634 | High Similarity | NPC164427 |
0.8616 | High Similarity | NPC205918 |
0.8614 | High Similarity | NPC473094 |
0.8606 | High Similarity | NPC75944 |
0.8596 | High Similarity | NPC208069 |
0.8589 | High Similarity | NPC155302 |
0.8589 | High Similarity | NPC161947 |
0.8571 | High Similarity | NPC473113 |
0.8571 | High Similarity | NPC175192 |
0.8571 | High Similarity | NPC99381 |
0.8554 | High Similarity | NPC472150 |
0.8554 | High Similarity | NPC175082 |
0.8545 | High Similarity | NPC120677 |
0.8545 | High Similarity | NPC74371 |
0.8519 | High Similarity | NPC478223 |
0.8509 | High Similarity | NPC155686 |
0.8503 | High Similarity | NPC225419 |
0.8503 | High Similarity | NPC283041 |
0.8503 | High Similarity | NPC103633 |
0.85 | High Similarity | NPC207346 |
0.85 | High Similarity | NPC46564 |
0.8485 | Intermediate Similarity | NPC48860 |
0.8485 | Intermediate Similarity | NPC191360 |
0.8466 | Intermediate Similarity | NPC472889 |
0.8466 | Intermediate Similarity | NPC246466 |
0.8462 | Intermediate Similarity | NPC3732 |
0.8457 | Intermediate Similarity | NPC478133 |
0.8452 | Intermediate Similarity | NPC137460 |
0.8447 | Intermediate Similarity | NPC253904 |
0.8447 | Intermediate Similarity | NPC321363 |
0.8447 | Intermediate Similarity | NPC327225 |
0.8443 | Intermediate Similarity | NPC20237 |
0.843 | Intermediate Similarity | NPC254588 |
0.8424 | Intermediate Similarity | NPC476929 |
0.8424 | Intermediate Similarity | NPC472153 |
0.8424 | Intermediate Similarity | NPC201560 |
0.8421 | Intermediate Similarity | NPC272656 |
0.8415 | Intermediate Similarity | NPC477410 |
0.8412 | Intermediate Similarity | NPC469393 |
0.8402 | Intermediate Similarity | NPC313717 |
0.8402 | Intermediate Similarity | NPC315306 |
0.8395 | Intermediate Similarity | NPC478218 |
0.8393 | Intermediate Similarity | NPC150131 |
0.8385 | Intermediate Similarity | NPC46882 |
0.8385 | Intermediate Similarity | NPC132990 |
0.8383 | Intermediate Similarity | NPC297404 |
0.8383 | Intermediate Similarity | NPC11608 |
0.8383 | Intermediate Similarity | NPC191930 |
0.8383 | Intermediate Similarity | NPC470735 |
0.8383 | Intermediate Similarity | NPC329647 |
0.8375 | Intermediate Similarity | NPC120171 |
0.8375 | Intermediate Similarity | NPC44378 |
0.8375 | Intermediate Similarity | NPC280753 |
0.8364 | Intermediate Similarity | NPC472962 |
0.8364 | Intermediate Similarity | NPC472961 |
0.8364 | Intermediate Similarity | NPC470810 |
0.8354 | Intermediate Similarity | NPC477833 |
0.8353 | Intermediate Similarity | NPC118128 |
0.8353 | Intermediate Similarity | NPC121333 |
0.8344 | Intermediate Similarity | NPC326910 |
0.8344 | Intermediate Similarity | NPC472890 |
0.8344 | Intermediate Similarity | NPC208173 |
0.8344 | Intermediate Similarity | NPC170189 |
0.8344 | Intermediate Similarity | NPC69043 |
0.8344 | Intermediate Similarity | NPC478230 |
0.8344 | Intermediate Similarity | NPC478221 |
0.8333 | Intermediate Similarity | NPC477517 |
0.8333 | Intermediate Similarity | NPC167903 |
0.8333 | Intermediate Similarity | NPC186746 |
0.8333 | Intermediate Similarity | NPC478220 |
0.8323 | Intermediate Similarity | NPC56204 |
0.8323 | Intermediate Similarity | NPC469619 |
0.8323 | Intermediate Similarity | NPC249181 |
0.8323 | Intermediate Similarity | NPC469670 |
0.8323 | Intermediate Similarity | NPC62354 |
0.8323 | Intermediate Similarity | NPC476931 |
0.8313 | Intermediate Similarity | NPC112816 |
0.8313 | Intermediate Similarity | NPC94781 |
0.8313 | Intermediate Similarity | NPC101043 |
0.8313 | Intermediate Similarity | NPC117985 |
0.8313 | Intermediate Similarity | NPC471103 |
0.8313 | Intermediate Similarity | NPC474239 |
0.8313 | Intermediate Similarity | NPC306799 |
0.8304 | Intermediate Similarity | NPC154986 |
0.8302 | Intermediate Similarity | NPC136878 |
0.8294 | Intermediate Similarity | NPC103307 |
0.8294 | Intermediate Similarity | NPC74559 |
0.8293 | Intermediate Similarity | NPC472050 |
0.8293 | Intermediate Similarity | NPC303255 |
0.8293 | Intermediate Similarity | NPC20530 |
0.8293 | Intermediate Similarity | NPC215917 |
0.8293 | Intermediate Similarity | NPC10754 |
0.8291 | Intermediate Similarity | NPC477409 |
0.8284 | Intermediate Similarity | NPC158761 |
0.8284 | Intermediate Similarity | NPC470456 |
0.8282 | Intermediate Similarity | NPC137301 |
0.8282 | Intermediate Similarity | NPC312482 |
0.8282 | Intermediate Similarity | NPC478231 |
0.8276 | Intermediate Similarity | NPC315221 |
0.8274 | Intermediate Similarity | NPC470457 |
0.8274 | Intermediate Similarity | NPC234052 |
0.8272 | Intermediate Similarity | NPC70016 |
0.8272 | Intermediate Similarity | NPC471229 |
0.8272 | Intermediate Similarity | NPC470569 |
0.8272 | Intermediate Similarity | NPC215921 |
0.8269 | Intermediate Similarity | NPC136649 |
0.8263 | Intermediate Similarity | NPC211107 |
0.8263 | Intermediate Similarity | NPC473961 |
0.8263 | Intermediate Similarity | NPC472964 |
0.8263 | Intermediate Similarity | NPC215612 |
0.8261 | Intermediate Similarity | NPC89442 |
0.8256 | Intermediate Similarity | NPC294149 |
0.8253 | Intermediate Similarity | NPC470183 |
0.8253 | Intermediate Similarity | NPC472902 |
0.8253 | Intermediate Similarity | NPC188649 |
0.8253 | Intermediate Similarity | NPC471976 |
0.825 | Intermediate Similarity | NPC469425 |
0.8246 | Intermediate Similarity | NPC294501 |
0.8246 | Intermediate Similarity | NPC472620 |
0.8242 | Intermediate Similarity | NPC179732 |
0.8242 | Intermediate Similarity | NPC478225 |
0.8242 | Intermediate Similarity | NPC302258 |
0.8239 | Intermediate Similarity | NPC478019 |
0.8239 | Intermediate Similarity | NPC30890 |
0.8235 | Intermediate Similarity | NPC286074 |
0.8235 | Intermediate Similarity | NPC242395 |
0.8235 | Intermediate Similarity | NPC152477 |
0.8235 | Intermediate Similarity | NPC222455 |
0.8235 | Intermediate Similarity | NPC188079 |
0.8235 | Intermediate Similarity | NPC54903 |
0.8232 | Intermediate Similarity | NPC478161 |
0.8232 | Intermediate Similarity | NPC317585 |
0.8232 | Intermediate Similarity | NPC478159 |
0.8229 | Intermediate Similarity | NPC182693 |
0.8229 | Intermediate Similarity | NPC313452 |
0.8228 | Intermediate Similarity | NPC127857 |
0.8225 | Intermediate Similarity | NPC235610 |
0.8225 | Intermediate Similarity | NPC173292 |
0.8225 | Intermediate Similarity | NPC469394 |
0.8225 | Intermediate Similarity | NPC470462 |
0.8221 | Intermediate Similarity | NPC216035 |
0.8221 | Intermediate Similarity | NPC115249 |
0.8221 | Intermediate Similarity | NPC184284 |
0.8221 | Intermediate Similarity | NPC171651 |
0.8221 | Intermediate Similarity | NPC35567 |
0.8221 | Intermediate Similarity | NPC243171 |
0.8221 | Intermediate Similarity | NPC217149 |
0.8221 | Intermediate Similarity | NPC474843 |
0.8221 | Intermediate Similarity | NPC478224 |
0.8221 | Intermediate Similarity | NPC275878 |
0.8221 | Intermediate Similarity | NPC76041 |
0.8221 | Intermediate Similarity | NPC210597 |
0.8218 | Intermediate Similarity | NPC244903 |
0.8214 | Intermediate Similarity | NPC474240 |
0.8214 | Intermediate Similarity | NPC134047 |
0.8214 | Intermediate Similarity | NPC41301 |
0.8214 | Intermediate Similarity | NPC121995 |
0.8214 | Intermediate Similarity | NPC272750 |
0.8214 | Intermediate Similarity | NPC476822 |
0.8214 | Intermediate Similarity | NPC470459 |
0.8214 | Intermediate Similarity | NPC173729 |
0.8214 | Intermediate Similarity | NPC223006 |
0.821 | Intermediate Similarity | NPC147735 |
0.821 | Intermediate Similarity | NPC470568 |
0.821 | Intermediate Similarity | NPC267117 |
0.821 | Intermediate Similarity | NPC255641 |
0.821 | Intermediate Similarity | NPC290954 |
0.8205 | Intermediate Similarity | NPC477408 |
0.8205 | Intermediate Similarity | NPC114620 |
0.8205 | Intermediate Similarity | NPC103337 |
0.8204 | Intermediate Similarity | NPC3629 |
0.8204 | Intermediate Similarity | NPC471499 |
0.8204 | Intermediate Similarity | NPC288602 |
0.8204 | Intermediate Similarity | NPC269117 |
0.8204 | Intermediate Similarity | NPC96031 |
0.8204 | Intermediate Similarity | NPC308992 |
0.8204 | Intermediate Similarity | NPC311740 |
0.8204 | Intermediate Similarity | NPC88841 |
0.8202 | Intermediate Similarity | NPC314672 |
0.8199 | Intermediate Similarity | NPC191634 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC316457 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8503 | High Similarity | NPD3751 | Discontinued |
0.8485 | Intermediate Similarity | NPD3787 | Discontinued |
0.8295 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.8098 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8061 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8059 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8059 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8059 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8024 | Intermediate Similarity | NPD7075 | Discontinued |
0.8012 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8012 | Intermediate Similarity | NPD5402 | Approved |
0.8012 | Intermediate Similarity | NPD7473 | Discontinued |
0.8 | Intermediate Similarity | NPD6801 | Discontinued |
0.7966 | Intermediate Similarity | NPD8150 | Discontinued |
0.7966 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7964 | Intermediate Similarity | NPD3882 | Suspended |
0.7952 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7952 | Intermediate Similarity | NPD7819 | Suspended |
0.7941 | Intermediate Similarity | NPD6232 | Discontinued |
0.7929 | Intermediate Similarity | NPD5494 | Approved |
0.7919 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7892 | Intermediate Similarity | NPD1934 | Approved |
0.788 | Intermediate Similarity | NPD6778 | Approved |
0.788 | Intermediate Similarity | NPD6781 | Approved |
0.788 | Intermediate Similarity | NPD6776 | Approved |
0.788 | Intermediate Similarity | NPD6779 | Approved |
0.788 | Intermediate Similarity | NPD6780 | Approved |
0.788 | Intermediate Similarity | NPD6782 | Approved |
0.788 | Intermediate Similarity | NPD6777 | Approved |
0.7879 | Intermediate Similarity | NPD6599 | Discontinued |
0.7849 | Intermediate Similarity | NPD7435 | Discontinued |
0.7844 | Intermediate Similarity | NPD2801 | Approved |
0.784 | Intermediate Similarity | NPD6799 | Approved |
0.7809 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7791 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD6959 | Discontinued |
0.7759 | Intermediate Similarity | NPD3818 | Discontinued |
0.7751 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.774 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7727 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7716 | Intermediate Similarity | NPD6190 | Approved |
0.7714 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7711 | Intermediate Similarity | NPD3226 | Approved |
0.7706 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7697 | Intermediate Similarity | NPD5403 | Approved |
0.7692 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7684 | Intermediate Similarity | NPD7251 | Discontinued |
0.7683 | Intermediate Similarity | NPD5401 | Approved |
0.766 | Intermediate Similarity | NPD7698 | Approved |
0.766 | Intermediate Similarity | NPD7696 | Phase 3 |
0.766 | Intermediate Similarity | NPD7697 | Approved |
0.764 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7636 | Intermediate Similarity | NPD1512 | Approved |
0.7627 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7625 | Intermediate Similarity | NPD2796 | Approved |
0.7619 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7619 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7609 | Intermediate Similarity | NPD6534 | Approved |
0.7609 | Intermediate Similarity | NPD6535 | Approved |
0.7604 | Intermediate Similarity | NPD7874 | Approved |
0.7604 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7598 | Intermediate Similarity | NPD8312 | Approved |
0.7598 | Intermediate Similarity | NPD8313 | Approved |
0.7592 | Intermediate Similarity | NPD7701 | Phase 2 |
0.7582 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7576 | Intermediate Similarity | NPD2533 | Approved |
0.7576 | Intermediate Similarity | NPD2534 | Approved |
0.7576 | Intermediate Similarity | NPD2532 | Approved |
0.7576 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7574 | Intermediate Similarity | NPD37 | Approved |
0.7571 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7565 | Intermediate Similarity | NPD7801 | Approved |
0.7562 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7546 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7544 | Intermediate Similarity | NPD4965 | Approved |
0.7544 | Intermediate Similarity | NPD4966 | Approved |
0.7544 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7531 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7531 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7515 | Intermediate Similarity | NPD1511 | Approved |
0.7515 | Intermediate Similarity | NPD7411 | Suspended |
0.7514 | Intermediate Similarity | NPD7054 | Approved |
0.7487 | Intermediate Similarity | NPD7699 | Phase 2 |
0.7487 | Intermediate Similarity | NPD7700 | Phase 2 |
0.7486 | Intermediate Similarity | NPD6559 | Discontinued |
0.7486 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7472 | Intermediate Similarity | NPD7472 | Approved |
0.7471 | Intermediate Similarity | NPD1247 | Approved |
0.7469 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7469 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7469 | Intermediate Similarity | NPD2346 | Discontinued |
0.7457 | Intermediate Similarity | NPD6234 | Discontinued |
0.7438 | Intermediate Similarity | NPD1607 | Approved |
0.7435 | Intermediate Similarity | NPD8319 | Approved |
0.7435 | Intermediate Similarity | NPD8320 | Phase 1 |
0.7427 | Intermediate Similarity | NPD5761 | Phase 2 |
0.7427 | Intermediate Similarity | NPD5760 | Phase 2 |
0.7421 | Intermediate Similarity | NPD1240 | Approved |
0.7421 | Intermediate Similarity | NPD6823 | Phase 2 |
0.7407 | Intermediate Similarity | NPD2935 | Discontinued |
0.7396 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7386 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7378 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7371 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7346 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7326 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7301 | Intermediate Similarity | NPD6100 | Approved |
0.7301 | Intermediate Similarity | NPD6099 | Approved |
0.7299 | Intermediate Similarity | NPD3749 | Approved |
0.7293 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7293 | Intermediate Similarity | NPD8368 | Discontinued |
0.7278 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7263 | Intermediate Similarity | NPD7228 | Approved |
0.7263 | Intermediate Similarity | NPD8285 | Discontinued |
0.7262 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7257 | Intermediate Similarity | NPD919 | Approved |
0.7256 | Intermediate Similarity | NPD5763 | Approved |
0.7256 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7256 | Intermediate Similarity | NPD5762 | Approved |
0.7247 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7246 | Intermediate Similarity | NPD3300 | Phase 2 |
0.7239 | Intermediate Similarity | NPD2799 | Discontinued |
0.7239 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7229 | Intermediate Similarity | NPD3750 | Approved |
0.7228 | Intermediate Similarity | NPD8155 | Clinical (unspecified phase) |
0.7219 | Intermediate Similarity | NPD6273 | Approved |
0.7216 | Intermediate Similarity | NPD7211 | Clinical (unspecified phase) |
0.7202 | Intermediate Similarity | NPD7390 | Discontinued |
0.7197 | Intermediate Similarity | NPD1470 | Approved |
0.7194 | Intermediate Similarity | NPD8151 | Discontinued |
0.7193 | Intermediate Similarity | NPD7458 | Discontinued |
0.7188 | Intermediate Similarity | NPD6798 | Discontinued |
0.7175 | Intermediate Similarity | NPD8127 | Discontinued |
0.7174 | Intermediate Similarity | NPD8407 | Phase 2 |
0.716 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.716 | Intermediate Similarity | NPD6355 | Discontinued |
0.7159 | Intermediate Similarity | NPD5537 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD2798 | Approved |
0.7143 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7143 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7143 | Intermediate Similarity | NPD7236 | Approved |
0.7134 | Intermediate Similarity | NPD3748 | Approved |
0.7126 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7126 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7118 | Intermediate Similarity | NPD7314 | Clinical (unspecified phase) |
0.7112 | Intermediate Similarity | NPD8435 | Approved |
0.7104 | Intermediate Similarity | NPD7240 | Approved |
0.7104 | Intermediate Similarity | NPD6765 | Approved |
0.7104 | Intermediate Similarity | NPD6764 | Approved |
0.7099 | Intermediate Similarity | NPD943 | Approved |
0.7099 | Intermediate Similarity | NPD4060 | Phase 1 |
0.709 | Intermediate Similarity | NPD6212 | Phase 3 |
0.709 | Intermediate Similarity | NPD6214 | Clinical (unspecified phase) |
0.709 | Intermediate Similarity | NPD6213 | Phase 3 |
0.7081 | Intermediate Similarity | NPD2313 | Discontinued |
0.7072 | Intermediate Similarity | NPD7799 | Discontinued |
0.7068 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7066 | Intermediate Similarity | NPD2800 | Approved |
0.7056 | Intermediate Similarity | NPD2403 | Approved |
0.7055 | Intermediate Similarity | NPD230 | Phase 1 |
0.7055 | Intermediate Similarity | NPD447 | Suspended |
0.7051 | Intermediate Similarity | NPD1201 | Approved |
0.7047 | Intermediate Similarity | NPD4580 | Approved |
0.7044 | Intermediate Similarity | NPD4111 | Phase 1 |
0.7039 | Intermediate Similarity | NPD5710 | Approved |
0.7039 | Intermediate Similarity | NPD5711 | Approved |
0.7039 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7035 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7035 | Intermediate Similarity | NPD7239 | Suspended |
0.7035 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.703 | Intermediate Similarity | NPD7033 | Discontinued |
0.7024 | Intermediate Similarity | NPD7003 | Approved |
0.7021 | Intermediate Similarity | NPD8361 | Approved |
0.7021 | Intermediate Similarity | NPD8360 | Approved |
0.7012 | Intermediate Similarity | NPD6651 | Approved |
0.7011 | Intermediate Similarity | NPD5030 | Phase 2 |
0.7006 | Intermediate Similarity | NPD2424 | Discontinued |
0.7 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.6994 | Remote Similarity | NPD2651 | Approved |
0.6994 | Remote Similarity | NPD2649 | Approved |
0.699 | Remote Similarity | NPD4583 | Approved |
0.699 | Remote Similarity | NPD4582 | Approved |
0.6988 | Remote Similarity | NPD2438 | Suspended |
0.6988 | Remote Similarity | NPD1551 | Phase 2 |
0.6979 | Remote Similarity | NPD2974 | Approved |
0.6979 | Remote Similarity | NPD2975 | Approved |
0.6979 | Remote Similarity | NPD2973 | Approved |
0.6977 | Remote Similarity | NPD920 | Approved |
0.6976 | Remote Similarity | NPD7907 | Approved |
0.6975 | Remote Similarity | NPD3764 | Approved |
0.6975 | Remote Similarity | NPD6859 | Clinical (unspecified phase) |
0.6973 | Remote Similarity | NPD5034 | Approved |
0.6973 | Remote Similarity | NPD36 | Approved |
0.6973 | Remote Similarity | NPD4954 | Approved |
0.6973 | Remote Similarity | NPD4955 | Approved |
0.6973 | Remote Similarity | NPD5028 | Approved |
0.6973 | Remote Similarity | NPD5026 | Approved |
0.6971 | Remote Similarity | NPD6844 | Discontinued |
0.6964 | Remote Similarity | NPD5698 | Clinical (unspecified phase) |
0.6961 | Remote Similarity | NPD4665 | Approved |
PubChem CID   | 403671 |
ChEMBL   | CHEMBL588946 |
ZINC   |
Molecular Weight:   | 420.14 |
ALogP:   | -3.349 |
MLogP:   | 2.78 |
XLogP:   | -1.205 |
# Rotatable Bonds:   | 11 |
Polar Surface Area:   | 138.35 |
# H-Bond Aceptor:   | 8 |
# H-Bond Donor:   | 3 |
# Rings:   | 5 |
# Heavy Atoms:   | 30 |